|
Statements of Operations and Comprehensive Loss (USD $)
|
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Revenue: | ||
| Grant revenue | $ 84,980us-gaap_RevenueFromGrants | |
| Collaboration revenue | 50,000trvn_CollaborationRevenue | |
| Total revenue | 134,980us-gaap_Revenues | |
| Operating expenses: | ||
| General and administrative | 9,403,254us-gaap_GeneralAndAdministrativeExpense | 4,718,047us-gaap_GeneralAndAdministrativeExpense |
| Research and development | 40,546,666us-gaap_ResearchAndDevelopmentExpense | 18,762,219us-gaap_ResearchAndDevelopmentExpense |
| Total operating expenses | 49,949,920us-gaap_OperatingExpenses | 23,480,266us-gaap_OperatingExpenses |
| Loss from operations | (49,949,920)us-gaap_OperatingIncomeLoss | (23,345,286)us-gaap_OperatingIncomeLoss |
| Other income (expense): | ||
| Change in fair value of warrant liability | 122,412us-gaap_FairValueAdjustmentOfWarrants | 241,478us-gaap_FairValueAdjustmentOfWarrants |
| Miscellaneous income | 184,015us-gaap_OtherNonoperatingIncome | 1,245us-gaap_OtherNonoperatingIncome |
| Loss on asset disposal | (4,104)us-gaap_GainLossOnSaleOfOtherAssets | |
| Interest income | 17,372us-gaap_InvestmentIncomeInterest | 884us-gaap_InvestmentIncomeInterest |
| Interest expense | (70,650)us-gaap_InterestExpense | (149,756)us-gaap_InterestExpense |
| Total other income | 249,045us-gaap_NonoperatingIncomeExpense | 93,851us-gaap_NonoperatingIncomeExpense |
| Net loss | (49,700,875)us-gaap_NetIncomeLoss | (23,251,435)us-gaap_NetIncomeLoss |
| Accretion of redeemable convertible preferred stock | (28,521)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment | (333,710)us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment |
| Net loss attributable to common stockholders | (49,729,396)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic | (23,585,145)us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic |
| Other comprehensive income, net: | ||
| Change in unrealized loss | (18,782)us-gaap_AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax | |
| Other comprehensive loss | (18,782)us-gaap_OtherComprehensiveIncomeLossNetOfTax | |
| Comprehensive loss | $ (49,748,178)us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | $ (23,585,145)us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest |
| Per share information: | ||
| Net loss per share of common stock, basic and diluted (in dollars per share) | $ (2.02)us-gaap_EarningsPerShareBasicAndDiluted | $ (29.71)us-gaap_EarningsPerShareBasicAndDiluted |
| Weighted average shares outstanding, basic and diluted (in shares) | 24,655,603us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted | 793,806us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted |
| X | ||||||||||
|
- Definition
Revenue earned during the period from a research collaboration with a pharmaceutical company. No definition available.
|
| X | ||||||||||
|
- Definition
The change in unrealized holding gain (loss), net of tax, on available-for-sale securities included in a separate component of shareholders' equity during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) on sale or disposal of other assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of other income amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) profits on securities (net of losses), and (d) miscellaneous other income items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
|
- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|